The global wound dressing market size is expected to reach USD 27.6 billion by 2027 at a CAGR of 8.6% from USD 17.9 billion in 2020. Chronic wounds cause issues such as infection, ulceration, and insufficient blood supply, lengthening the time it takes for the wound to heal. Venous ulcers, diabetic foot ulcers, and pressure ulcers are the most frequent chronic sores. In recent years, wound dressing solutions and adequate care to address the underlying issue have gained popularity. The wound is a disruption of skin epithelial lining or mucosa which results in thermal or physical damage. Depending upon the healing nature and duration, a wound is classified into two types that is chronic wounds and acute wounds. Wounds can be caused because of the incisions made in the body during surgeries. A wound dressing is treating the wounds by both external and internal surgical procedures. Traditional wound dressings are used to treat acute wounds while advanced wound dressings are used to treat chronic wounds. Global Wound Dressing Market is one of the most promising markets in the medical field. Major players in global Wound Dressing market are adopting various growth strategies such as collaborations and partnerships, acquisitions and mergers, product launches and investments on R&D activities. For Instance, In May 2013, TriStar Wellness Solutions, Inc. a health and wellness company signed the 3-year exclusive licensing agreement with Polytherapeutics, Inc. for its Pharma drug delivery technology, for OTC products focused on the treatment of specific skin conditions and wound care applications. On April 14, 2016, Integra Life Sciences Holdings Corporation and Vomaris Wound Care, Inc. entered into an agreement for marketing advanced wound care products.